CompoAtlas

JOINT RELIEF

Natural health product licensed in Canada

Licence holder
Exzell Pharma Inc.
NPN or DIN-HM
80006175
Status
Inactive licence
Licence date
17 June 2008
Revision date
13 May 2021
Form
Caplet
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de glucosamine

Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes

500 mgNot calculated
Sulfate de glucosamine

Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crabes

500 mgNot calculated
Harpagophytum procumbens

Source : Racine

Extraction ratio : 6:1

Dry plant equivalent : 1,500 mg

250 mgNot calculated

Non-medicinal ingredients

Hypromellose, Silicon dioxide colloïdal, Stéarate de magnésium, Cellulose - microcrystalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Caplet3 Tous les jours

Uses authorised in Canada

Helps to relieve joint pain associated with osteoarthritis. Factor in building of healthy cartilage.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80006175

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line